Posts Tagged ‘FDA’

FCC FDA Joint Meeting Discusses Challenges, Successes of Broadband in Healthcare

Broadband's Impact, Health, Mobile Broadband, Spectrum July 26th, 2010

WASHINGTON, July 26, 2010 – A panel of industry representatives from companies manufacturing new broadband-capable medical tools said they were looking for ways to have these technologies integrated into the current medical systems.

FCC, FDA Partner to Address Health Technologies Using Spectrum

Broadband Updates, Broadband's Impact, FCC, FCC Workshops, Health, National Broadband Plan, Spectrum, Wireless July 26th, 2010

WASHINGTON, July 26, 2010 – To plug it in and keep it beating, these two agencies must keep on meeting was the general theme of a panel discussion Monday convened by the Federal Communications Commission and Food and Drug Administration to address the current state of wireless health, and the lessons learned in those fields.

FCC and FDA Sign a Joint Memorandum Outlining Responsibilities for Wireless Healthcare

Uncategorized July 26th, 2010

WASHINGTON, July 26, 2010 – Federal Communications Commission Chairman Julius Genachowski and Food and Drug Administration Commissioner Margaret Hamburg signed a statement of principles on wireless healthcare at a joint FCC/FDA meeting on wireless medical technology.

FCC Net Neutrality Workshop Examines Importance of Transparency

Broadband Data, FCC Workshops, National Broadband Plan, Net Neutrality, Transparency, Wireless January 21st, 2010

WASHINGTON, January 21, 2010 – The Federal Communications Commission in a Tuesday workshop explored consumer choice, user control of their online experience and the importance of transparency.

The agency’s fourth Open Internet Workshop on Consumers, Transparency and the Open Internet focused on the sixth principle of network neutrality – transparency.

FDA Considers Drug Promotion Requirements for Broadband Age

Broadband's Impact November 15th, 2009

WASHINGTON, November 15, 2009 – The Food and Drug Administration last week considered how regulated medical products such as prescription drugs for humans or animals should be promoted on the Internet and through the use of social media tools.

“The FDA has been widely criticized for not providing guidance for drug companies eager to promote their products on the internet,” according to Kate Greenwood, a faculty member of Seton Hall University School of Law’s Center for Health & Pharmaceutical Law & Policy. “In recent months, the FDA has indicated that it is open to providing internet-specific marketing guidance,” she said.

Additional Pages

or Visit the Archives